Vet Talk: Caring for a senior pet is like caring for an ageing family member
Geriatric care means slowing down with your pets and recognising that your presence, patience and love are the greatest forms of care.
As a veterinarian focusing on palliative and geriatric care, I have come to appreciate the universal truth shared by all living beings – be they dogs, cats or humans. Ageing is inevitable and with it comes unique challenges.
While we cannot halt time, we can shape how our pets experience their later years.
Geriatric care goes beyond managing illness. It is about preserving comfort, dignity and quality of life throughout the later stages of life.
The subtle signs of ageing in pets often mirror those in humans, but unfold over a shorter period.
As pets enter their senior years, they may sleep more, move more slowly and take longer to get up.
Physical activities with them may become shorter, as they tire more easily and foods once enjoyed may no longer agree with their digestion.
As our beloved pets age, it is natural to be concerned as their needs and vulnerabilities change.
Top stories
Swipe. Select. Stay informed.
Singapore Government looking at enhancing laws around vaping to tackle issue of drug-laced vapes in Singapore
Singapore Why the vape scourge in Singapore concerns everyone
Singapore I lost my daughter to Kpod addiction: Father of 19-year-old shares heartbreak and lessons
Singapore Organised crime groups pushing drug-laced vapes in Asia including Singapore: UN
Asia Why China's high-end hotels are setting up food stalls outside their doors
Singapore Geothermal energy present in S'pore, but greater study on costs, stability needed, say experts
Singapore Prison school to NUS: At 36, former drug abuser finds it's never too late to get a degree
Singapore Driver arrested after 66-year-old woman dies in car crash at Geylang pasar malam
Mobility issues become more apparent and their senses, such as hearing and sight, may decline.
Some pets develop cognitive dysfunction (dementia), causing behavioural changes or confusion. Chronic or terminal illnesses, such as organ failure or cancer, may also arise. These changes are not just physical and can be emotionally life-changing for the pets' families as well.
Regular veterinary check-ups and screening tests
Caring for a senior pet is no different from caring for one's ageing family members.
Monitoring healthy senior pets through regular veterinary check-ups and screening tests every six months can help detect health changes early and support their well-being through timely care.
Early detection is crucial in helping pets enjoy longer, healthier lives. For example, catching kidney disease early allows for dietary and lifestyle adjustments that will slow its progression.
Identifying heart failure early helps families manage symptoms at home and extend their pet's life.
In cancer cases, early diagnosis can determine if curative or palliative care is appropriate. When a cure is not possible, early diagnosis ensures comfort and practical support.
The care of senior pets involves more than medical treatment. It is about spending intentional time, maintaining gentle routines and adapting to their environment.
Small changes such as these can make a big difference:
Shorter but more frequent walks that suit the pet's energy level
Soft, supportive bedding for joint comfort
Placing carpets or yoga mats throughout the house for pets with walking difficulties
Keeping pets safe in public spaces by minimising rough play or overstimulation
Providing small stepping stools or low furniture for cats so they can reach their favourite spots easily
Geriatric care means slowing down with your pets and recognising that your presence, patience and love are the greatest forms of care.
Quiet days at home, relaxing at a pet-friendly cafe or taking slow walks in familiar places can be just as meaningful and joyful as the more active days of their youth.
What matters most
Humans and animals alike will grow old one day. What matters most is not when we die, but how we journey there. It is about living a whole life in healthier years and receiving compassionate care in the twilight of life.
To every pet owner navigating this stage or grieving the loss of a beloved companion, I hope you carry this with you: Remember the joy you shared, the warmth of your bond, the routines, playtimes and all the little moments that make up your lives together.
Pets do not measure the quality of their lives by their lifespan. What stays with them is the love, comfort and steady presence of those who remain by their side.
The bond you share with your pets is irreplaceable. Cherish them and the time you have during their golden years. These moments will become lasting memories that will stay with you forever.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
7 hours ago
- Straits Times
Forum: End of free test kit distribution can hurt fight against cancer here
Sign up now: Get ST's newsletters delivered to your inbox C olorectal cancer remains one of the leading causes of cancer-related deaths among Singaporeans aged 50 and above, particularly when not detected early. For years, the Singapore Cancer Society, with government support, has played a vital role in raising public awareness and encouraging early screening through its outreach campaigns. One of its most impactful efforts was the community distribution of free faecal immunochemical test kits – a simple yet effective tool to detect hidden blood in stools, which can be an early sign of colorectal cancer. As someone who regularly responded to these screening initiatives, I am grateful for this public health effort. It has helped to normalise the conversation around cancer screening and enabled early detection for many Singaporeans, especially those who would otherwise not have sought screening on their own. However, I was surprised and disheartened to learn recently that the Singapore Cancer Society has stopped distributing these kits, which now have to be collected through Healthier SG healthcare providers, where doctor consultation and screening test fees may apply. Given the ageing population in Singapore and the proven effectiveness of early screening, this shift feels like a step backwards in our nation's fight against cancer. Top stories Swipe. Select. Stay informed. Singapore Govt will continue to support families, including growing group of seniors: PM Wong at PCF Family Day Singapore From Normal stream to Parliament: 3 Singapore politicians share their journeys World Deal or no deal? EU faces critical decision in response to Trump's latest tariff salvo Singapore Segregated recycling bins found to lower contamination rate as more spring up Sport Two participants injured after another breached safety protocol during Pesta Sukan archery event Asia Mahathir discharged from hospital after feeling fatigued during birthday gathering Singapore Medics treat 7 after blaze at HDB block lift lobby in Chai Chee Singapore I lost my daughter to Kpod addiction: Father of 19-year-old shares heartbreak and lessons Ho Kheng Tiong
Straits Times
7 hours ago
- Straits Times
Locally developed cancer drug shows promise as treatment for blindness; trial to start soon
Sign up now: Get ST's newsletters delivered to your inbox Professor Qi Zeng (seated) and her team of scientists, including Dr David Ang (standing behind her), have evaluated the drug known as PRL3-zumab for 20 years. SINGAPORE – A locally developed drug for cancer treatment will be used in a trial in Singapore on patients to prevent vision loss. It will be administered intravenously to patients with wet age-related macular degeneration (AMD) or diabetic retinopathy, both currently treated with a shot of medicine injected into the eye. The two conditions are among the most common causes of vision loss globally. In pre-clinical studies published in Nature Communications, the drug known as PRL3-zumab effectively reduced leakage from damaged blood vessels – a major cause of vision loss. This pointed to a possible new treatment option for patients whose eye conditions do not respond well to current therapies. The findings for the drug came from the A*Star Institute of Molecular and Cell Biology (IMCB), which had originally developed it, and its biotech spin-off Intra-ImmuSG. Wet AMD and diabetic retinopathy share a common treatment approach: periodic injections administered directly into the white part of the eye, or sclera, as often as once a month. This is done to reduce abnormal blood vessel growth and leakage. A*Star senior scientist David Ang Koon Hwee said he was driven to explore the intravenous application of PRL3-zumab for the two eye conditions after witnessing his late father struggle for several years with the injections to treat his diabetic eye complication. Moreover, a significant portion of the patients who need these injections do not respond adequately to them. The pre-clinical studies showed that the intravenous delivery of PRL3-zumab led to an 86 per cent greater reduction in abnormal blood vessel leakage, compared with injections into the eye. 'When the blood vessels are broken and start to leak, it is like a water pipe that is leaking... This drug can reduce the leakage,' said Dr Ang, who added that the current standard care treatments cannot be given intravenously because of their toxicity. PRL3-zumab has been tested in 210 advanced cancer patients so far, with a good safety profile, he said. Phase II trials for the drug were conducted in Singapore, the United States, China and, most recently, Malaysia. Professor Qi Zeng, A*Star IMCB senior principal scientist and founder of Intra-ImmuSG, said she and a team of researchers have evaluated the drug for 20 years now – it targets only diseased tissues and not normal, healthy tissues, rendering it very safe. She first identified the PRL3 protein, which is found in many cancers, in 1998. Singapore's Health Sciences Authority granted approval on June 16 for the human trial to test PRL3-zumab as an alternative intravenous treatment to eye injections in treating wet AMD and diabetic retinopathy. The safety trial, which will have 15 patients, is expected to begin by late 2025, following which more human trials will be needed to show that it is effective.
Straits Times
7 hours ago
- Straits Times
Healthcare innovation: AI-enhanced and enabled, but not AI-decided
How should the healthcare sector deal with the opportunities and risks that come with the tech revolution? Health Minister and Coordinating Minister for Social Policies Ong Ye Kung addressed the issue at the ninth CHI Innovate conference on July 10. The following is an edited text of his speech. With the power of AI in our hands, healthcare institutions need to use it judiciously and deploy it thoughtfully, says Health Minister Ong Ye Kung. The way healthcare uses AI is different from many other industries. We are not overwhelmed by it, in the way AI has disrupted the music, entertainment or transport sectors; or digitalisation has revamped the telecommunications, retail or financial services sector. This is because healthcare is an essential public service that cannot be substituted. It is also highly regulated. This means the determined and heavy hand of clinical governance can possibly keep out disruptive technological changes. In Singapore, we are, of course, not going to do that. On the other hand, healthcare systems around the world are disrupted by a separate force – not of technology, but of nature. And that is demography, and the progressive ageing of our population. Hence, the healthcare sector is in a unique, and I would say, advantageous position. We are confronting the biggest challenge of our generation, which is ageing. We have AI technology on our side, which we are in a position to titrate, introducing it judiciously into our system to help tackle our challenge. This also means healthcare leaders are in a special position to envision the future, mobilise people and synergise human skills and AI to benefit our patients. With that in mind, let me offer a few thoughts on what healthcare leaders need to do. Strategy and Vision First, we need to define and articulate our strategy – how are we serving customers differently? What is the big change? I find the example of PSA Singapore inspiring. I used to oversee the PSA as the minister for transport. PSA has been doing very well over the past few years. Despite the Covid-19 pandemic, supply chain disruptions and a setback in global trade, container volumes are rising. Top stories Swipe. Select. Stay informed. Singapore Govt will continue to support families, including growing group of seniors: PM Wong at PCF Family Day Singapore From Normal stream to Parliament: 3 Singapore politicians share their journeys World Deal or no deal? EU faces critical decision in response to Trump's latest tariff salvo Singapore Segregated recycling bins found to lower contamination rate as more spring up Sport Two participants injured after another breached safety protocol during Pesta Sukan archery event Asia Mahathir discharged from hospital after feeling fatigued during birthday gathering Singapore Medics treat 7 after blaze at HDB block lift lobby in Chai Chee Singapore I lost my daughter to Kpod addiction: Father of 19-year-old shares heartbreak and lessons PSA's ability to buck the trend can be partly attributed to a clear strategy. It is strengthening Singapore's position as a transshipment hub, by developing a network of ports around the world, so that they can offer shipping line alternatives during a supply chain disruption, and are able to plan routes around the world for maximum yield. Their AI-driven IT system made this strategy possible. But technology serves the strategy, not the other way round. Where PSA saw opportunity in global supply chain disruptions, we have to contend with changing patient mix due to ageing. More patients are older, with complex multiple conditions. They need preventive care that avoids triggering the conditions, and continual care after they are discharged from hospitals. Both preventive and continual care should be delivered in the community. But today, too much healthcare is still accumulated at the acute hospitals, which is the most expensive, often too late in the course of disease progression, and not necessarily the best setting for patients. The big change we need to bring about in healthcare today is to deliver as much care as possible, especially preventive and continuous care, through the community, by leveraging technology and manpower transformation. If we can do that, healthcare becomes a life companion, which is all round us, and not just delivered in hospitals and clinics. While in Saudi Arabia last year, my host showed me how a team of specialists was congregated in an operations room, attending via telehealth to patients in villages far across the desert. It is a model driven by geographical necessity. In the Netherlands, the company Buurtzorg, which means 'neighbourhood care' in Dutch, is a dominant player in home nursing care. They are organised into small teams of nurses, each taking care of an entire neighbourhood. The nurses are empowered to do many things – from assessing what the resident needs, to tailoring the care plans, to delivering the medical and support services. There are no long chains of command or complex governance frameworks to navigate. When the resident needs help, these nurses respond quickly and effectively. But they are well-supported, with direct access to specialists and nurse coaches in the backend, and an IT system to enable sharing of information. Singapore has demonstrated exciting possibilities to the world too. With Healthier SG, Age Well SG and Community Health Posts firmly in place, we have a springboard to build community care for the future, as a core shift in strategy. Fears, Concerns, Hope and Confidence Second, organisations need to recognise that change instils fear and concern amongst people, and these need to be addressed decisively. For example, workers will immediately worry that technology will render their service redundant. In an industry disrupted by technology and facing an uncertain future, it is better to be honest and forthright with people. But as I mentioned earlier, this is not the scenario in healthcare. We are facing rising patient loads, and technology is a potential saviour. I recall how several years ago, DBS Bank embarked on a major strategy to digitalise all its services. Workers were naturally worried, but the DBS leadership assured their staff that their jobs were safe, and they would instead train workers with new skills to adapt to the changes. In the ensuing years, DBS' share prices soared and at one point it was voted the best bank in the world. Patients and the public may have concerns too. For healthcare to be delivered seamlessly across all settings, and especially in the community, a patient's data needs to be captured and shared amongst healthcare providers whom he sought care from. There will be concerns about cybersecurity, which we are addressing by strengthening IT infrastructure. There will be worries about data privacy. We are therefore enacting new legislation, namely the proposed Health Information Act. Under the Act, beyond various data protection measures, a patient can choose to restrict the sharing of his medical data amongst the healthcare providers he sought care from. This is not an ideal arrangement and will undermine quality of care for the patient. However, by making this choice available, it addresses fears and instils confidence. Based on experience around the world, the number that eventually exercised the restriction has been very low. When there is greater availability of genetic data, there will be public concerns about how the data is used, and whether technology will inadvertently push us across societal ethical lines. The Ministry of Health (MOH) is therefore working on enhancing legislative protections on the use of genetic test information and will be conducting broad public consultation. This will provide greater clarity on what genetic information can be used for, such as for medical treatment, and what it cannot be used for, such as in deciding employment and insurance underwriting. Beyond addressing the fears and concerns arising from technology, we can also usher in hope and confidence about the future. Everyone can be empowered to participate in innovation and leverage technology to do a better job. DBS has managed to achieve this. 3M is also an inspiring example, where its leaders encourage ground-up innovation and allow employees to spend 15 per cent of their time on projects unrelated to their work. That positive culture has turned 3M from a mining company into a diverse manufacturer, including in electronics and healthcare. The Human Core Finally, organisations need to be careful not to devolve their core competencies to technology. As leaders, we also have a role in safeguarding humanity. We welcomed machines that could replace human labour. We applauded when computer software could process reams of paperwork in a moment, substituting human toil. We appreciated technology and servers that multiplied human memory. We were amazed when miniaturisation of computing power revolutionised human communication and perception. But with each advancement in technology, machines edge closer to the human core. We are happy to be relieved of labour, manual calculations, paperwork, even meeting face to face, but should we be happy when AI starts to replace human judgment, creativity, empathy and relationship? We should bear in mind even in the early phases of technological advancement, that are regarded as unmitigated good now, there were profound unintended negative consequences. When machines substituted human labour during the Industrial Revolution, it led to suppression of workers' rights, which in turn gave rise to socialism and nearly triggered World War III. As digital technology revolutionises human communications, it might have also rewired the minds of a generation. The evidence is still being debated, but ask any psychologist or counsellor, and they will tell you stories of how smart devices, video games or social media addiction have inflicted pain on young minds. There is no doubt AI will have a profound impact on society. We just don't know its full extent yet. We have heard warnings about the potential loss of creativity, independent thinking, ability to learn, and the resilience to seek answers to difficult problems. Healthcare, beyond medical knowledge, is all about the qualities of being human. With the power of AI in our hands, healthcare institutions need to use it judiciously and deploy it thoughtfully. Last year, I suggested a basic principle – make sure that healthcare is AI-enhanced and enabled, but not AI-decided. But this is only a general principle, which needs to be interpreted and implemented wisely in healthcare institutions. There is a good example in NHG Health, in the way it uses AI to read X-rays. AI will sieve out the normal readings and close the loop with the patients quickly. Those with abnormal readings will still be attended to by clinicians. That way, healthcare professionals do not lose their core competence. This is also why my current favourite AI use case in healthcare is the systemwide automation of clinical documentation – significant productivity gain, with negligible impact on our core competencies and humanity. I am glad we are having this in-person conference to discuss AI in healthcare. We welcome more human connections and networking, locally and internationally, to figure out how best to seize this opportunity of a lifetime to improve healthcare. To this end, MOH will be the first Asian country to join HealthAI's Global Regulatory Network as one of its Pioneer Countries. HealthAI is a non-profit organisation to help governments implement and strengthen the governance and regulation of AI in the healthcare sector. We will contribute to this effort. Thank you for listening to this speech, written without any AI assistance.
